Screening for rare sequence variants in the THAP1 gene in a primary dystonia cohort

Authors

  • Jeremy R.B. Newman BBiomolSci (Hons),

    1. Eskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane, Australia
    Search for more papers by this author
    • Dr. Newman and Dr. Lehn contributed equally to this work.

  • Alexander C. Lehn MD,

    1. Department of Neurology, Princess Alexandra Hospital, Brisbane, Australia
    Search for more papers by this author
    • Dr. Newman and Dr. Lehn contributed equally to this work.

  • Richard S. Boyle FRACP,

    1. Department of Neurology, Princess Alexandra Hospital, Brisbane, Australia
    Search for more papers by this author
  • Peter A. Silburn FRACP PhD,

    1. University of Queensland Centre for Clinical Research, School of Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia
    Search for more papers by this author
  • George D. Mellick PhD

    Corresponding author
    1. Eskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane, Australia
    2. Department of Neurology, Princess Alexandra Hospital, Brisbane, Australia
    • Correspondence to: Dr. George D. Mellick, Clinical Neuroscience Group, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Don Young Road, Nathan QLD 4111, Australia; G.Mellick@griffith.edu.au

    Search for more papers by this author

  • Funding agencies: Financial support for this project was obtained from internal funding for G.D.M.

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary